High Court considers requirements for an exclusive patent licence (Neurim v Mylan)

In the LexisNexis case analysis, Senior IP Associate, Will Smith, talks about the decision in the following matter: Neurim Pharmaceuticals (1991) Ltd & Anor v Generics UK Ltd (t\a MYLAN) [2020] EWHC 3270 (Pat). This case concerned the licensing of patented technology, specifically the use of licence terms relating to the control of proceedings. 

Click here to read more >

Full article available on PatentHub

Latest insights

More Insights
featured image

The pendulum swings back: Optis v Apple Court of Appeal FRAND judgment – Rapid reaction

22 minutes May 02 2025

Read More
featured image

Latest Developments Regulation Proposal - New Genomic Techniques

9 minutes May 01 2025

Read More
featured image

Patent Litigation in Practice Series: Doctrine of Equivalents and Patent disclaimers in Hungary

4 minutes Apr 29 2025

Read More